Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Bone marrow transplantation for severe aplastic anemia
R. Storb
,
R. E. Champlin
Research output
:
Contribution to journal
›
Review article
›
peer-review
38
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bone marrow transplantation for severe aplastic anemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bone Marrow Transplantation
100%
Severe Aplastic Anemia
100%
Graft Rejection
100%
Chronic Graft-versus-host Disease (cGVHD)
75%
Prednisone
50%
Cyclosporine
50%
Marrow Transplantation
50%
Graft-versus-host Disease (GvHD)
50%
Clinical Research
25%
Secondary Malignancy
25%
Cyclophosphamide
25%
Improved Survival
25%
Young Patients
25%
Living Donor
25%
Moderate to Severe
25%
Pretransplant
25%
Increasing Age
25%
Long-term Survival
25%
Unrelated Donor
25%
HLA-identical Sibling
25%
Allogeneic
25%
Conditioning Regimen
25%
Methotrexate
25%
Buffy Coat
25%
Female Donors
25%
Severe Acute
25%
Whole-body
25%
Effective Treatment
25%
Normal Hematopoiesis
25%
Patient Experience
25%
Marrow Cells
25%
Donor Age
25%
Transplantation Conditioning
25%
Histocompatibility Antigens
25%
Immunosuppressive Regimens
25%
Previous Pregnancy
25%
Limited Field
25%
Immune Disorders
25%
Immunomodulatory Drugs (IMiDs)
25%
Incidence of Complications
25%
Immunology and Microbiology
Bone Marrow Transplantation
100%
Immunosuppressive Drug
100%
Graft-Versus-Host Disease
100%
Ciclosporin
100%
Chronic Graft Versus Host Disease
100%
Aplastic Anemia
100%
Prednisone
100%
Cyclophosphamide
50%
Buffy Coat
50%
Hematopoiesis
50%
Acute Graft Versus Host Disease
50%
Methotrexate
50%
Long Term Survival
50%
Radiation Field
50%
Immune System Disorders
50%
Histocompatibility Antigen
50%
Pharmacology, Toxicology and Pharmaceutical Science
Aplastic Anemia
100%
Graft Rejection
100%
Diseases
50%
Prednisone
50%
Ciclosporin
50%
Graft Versus Host Reaction
50%
Chronic Graft Versus Host Disease
50%
Immunosuppressive Agent
50%
Cyclophosphamide
25%
Methotrexate
25%
Acute Graft Versus Host Disease
25%
Long Term Survival
25%
Clinical Research
25%
Histocompatibility Antigen
25%